Speaker illustration

Doctor Lukasz Szyda

Medical University of Lodz / Bieganski Hospital, Lodz (Poland)

Member of:

European Society of Cardiology

C-reactive protein level at admission is associated with increased mortality in critically ill cardiac patients with heparin-induced thrombocytopenia.

Event: ESC Acute CardioVascular Care 2024

Topic: Cardiac Care Unit (CCU), Intensive, and Critical Cardiovascular Care

Session: Poster session 1

Thumbnail

First-line treatment with oral anticoagulant predicts survival in acute cardiac patients with heparin-induced thrombocytopenia

Event: ESC Acute CardioVascular Care 2022

Topic: Cardiac Care Unit (CCU), Intensive, and Critical Cardiovascular Care

Session: e-Posters session

Thumbnail

Dabigatran as first-line treatment for heparin-induced thrombocytopenia in the intensive cardiac care setting.

Event: ESC Congress 2021 - The Digital Experience

Topic: Anticoagulants

Session: Pharmacology and pharmacotherapy e-posters

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb